Clinical Trial

INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations

Study acronym: INSIDE
Recruiting
View on ClinicalTrials.gov →
Summary
400 patients will be enrolled and divided into 3 cohorts: Cohort A: patients with high risk localized prostate cancer (PC) defined as \>cT3 or PSA \> 20 ng/mL or presence of ECE or SVI at mpMRI; Cohort B: patients with de novo metastatic hormone sensitive prostate cancer (mHSPC); Cohort C: patients with metastatic castration resistant prostate cancer (mCRPC) progressing on a standard treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-21.
Trial Details
NCT Number NCT06334809
Lead Sponsor Fondazione del Piemonte per l'Oncologia
Conditions Prostate Cancer
Enrollment 400 participants
Start Date 2023-03-09
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-12